Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease.
about
HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011The role of calmodulin kinase II in myocardial physiology and disease.Targeting ryanodine receptors for anti-arrhythmic therapy.CaMKII inhibitors: from research tools to therapeutic agentsAdenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton.Ca/Calmodulin-dependent Protein Kinase II in Heart Failure.Clickable 5'-γ-ferrocenyl adenosine triphosphate bioconjugates in kinase-catalyzed phosphorylations.
P2860
Q33815633-8D2A39D9-A398-4E12-A0B6-3CEC0DB1BA73Q37192039-6EF3966A-5D81-4C25-8048-3BC9DFE9081DQ37885158-1B166C75-07A2-41CD-B0C2-8FBF0E066C39Q38193798-2CD4B140-C535-4515-ABAB-29A378FE4EC2Q41940806-A674A450-F611-4100-BB21-45A6F6B13D00Q42717705-70C91D42-6BF9-433F-A601-8150F0A9F48AQ54290869-F58B4155-FC98-40B0-9A41-96411DD4A51F
P2860
Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@ast
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@en
type
label
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@ast
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@en
prefLabel
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@ast
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@en
P2093
P2860
P356
P1476
Disease mechanisms and emergin ...... ibitors in myocardial disease.
@en
P2093
Howard Schulman
Linda S Higgins
Mark E Anderson
P2860
P304
P356
10.1038/NCPCARDIO0585
P577
2006-08-01T00:00:00Z